Biotech Series B Investors & VC Firms
724 firms in this list, with a median first check of $500K. 165 of them lead rounds. Generated from verified public data and updated continuously.
Investissement Quebec
QuébecSeed–Growth
1 person
Wlanholding
ViennaSeed–Growth
1 person
Ela Capital
TorontoPre-Seed–Growth
3 people
Aescuvest
Frankfurt am MainSeed–Series B
1 person
Asclepius Life Sciences Fund, LP
New YorkSeed–Series B
3 people
Elmirate Capital
DubaiSeed–Late Stage$1M – $250M
Global Startup Acceleration Program (JETRO GSAP)
TokyoPre-Seed–Late Stage
Gaorong Capital
BeijingSeed–Series B
5 people
Strategic Investment Partners Inc.
TokyoSeed–Growth
2 people
KSP, Inc.
KawasakiSeed–Series B
1 person
Venbridge
TorontoSeed–Late Stage
1 person
Comway Capital Ltd.
ShanghaiSeed–Series B
Shinsei Capital Partners
TokyoPre-Seed–Late Stage
Ambix Venture Management, Llc
Mountain ViewPre-Seed–Late Stage
2 people
StarChain Ventures
Silicon ValleyPre-Seed–Series B
2 people
Hokkaido Venture Capital, Inc.
SapporoPre-Seed–Growth
1 person
SymBiosis
BentonvilleSeed–Late Stage
4 people
Boxer Capital, LLC
San DiegoSeed–Late Stage
1 person
E15
Hong KongPre-Seed–Late Stage
1 person
TriWise Capital
ShenzhenPre-Seed–Series B
1 person
Y Innovations
CambridgeSeed–Series B
1 person
YFY Biotech Management Company
TaipeiSeed–Series B
1 person
SEB Greentech Venture Capital
StockholmSeed–Growth$1.1M – $4.3M
4 people
Panda Capital
Seed–Late Stage
1 person
Related lists
Series B Investors & VC Firms (2951)Biotech Investors & VC Firms (2483)Biotech Seed Investors & VC Firms (2027)Series B Investors & VC Firms in North America (1738)Biotech Series A Investors & VC Firms (1627)Biotech Investors & VC Firms in North America (1601)Series B Investors & VC Firms in United States (1573)Biotech Investors & VC Firms in United States (1450)SaaS Series B Investors & VC Firms (1075)Series B Investors & VC Firms in Europe (1073)
Data sourced from public filings and firms' own websites — see our methodology.


















